This paper assesses the influence of a number of factors taken into account when a brand name drug is replaced by a generic one. It also evaluates responses of health professionals – physicians and pharmacist—and patients regarding the issue of switching. We compared and contrasted their responses in order to identify new points of cooperation for the intended benefit of the patient. Thus, the sample drew from all three groups, consisting of 50 doctors, 50 pharmacists, and 50 patients. We collected information regarding the age, residence, income level, and education level for the patients, and age and experience for the specialists. Based on responses to the survey, replacing the original medication with a generic one raises many issues, such as lack of information for the patient and specialist, lack of collaboration between physician and pharmacist, ineffective communication between specialist and patient, and the influence of the overall profit motive.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Dan Nicolae, Păduraru; Daniel, Ion; Adriana Elena, Nica; Florentina, Coman; Marius, Coțofană; Dumitru Cristinel, Badiu; Valentin Titus, Grigorean; Alexandra, Bolocan; and Octavian, Andronic
"The switch from patented medicine to the generic one: an option or a necessity?,"
Journal of Mind and Medical Sciences: Vol. 5
, Article 13.
Available at: https://scholar.valpo.edu/jmms/vol5/iss2/13